All In MedTech

Device Trial Radar · NCT04896645

Albuterol Integrated Adherence Monitoring in Children With Asthma

Last checked: Nov 19, 2026Latest source record: Nov 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

21

Actual

Start

Jun 1, 2021

Primary completion

Jun 22, 2022

Study completion Jun 22, 2022

Sponsor

Lead sponsor
Children's Hospital Los AngelesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Teva Pharmaceuticals USA
First posted
May 21, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 8 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators propose to evaluate whether an integrated electronic adherence monitoring albuterol rescue inhaler can improve proper use in a mostly minority and inner-city population of children treated for asthma at the Children's Hospital of Los Angeles

Conditions

  • Asthma in Children

Interventions

  • Digihaler Albuterol Device by TEVADevice

    Patient with asthma will have their regular albuterol rescue inhaler replaced with Digihaler, they will also be asked to perform gamified spirometry (Aluna) at home

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Asthma OutcomesTime frame: 3 months
  2. Asthma AdherenceTime frame: 3 months
  3. Asthma AdherenceTime frame: 3 months

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital Los Angeles

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.